The global clotrimazole vaginal cream market is anticipated to grow at a significant CAGR during the forecast period 2022-2028. Clotrimazole vaginal cream is a prescription treatment for fungal diseases such as athlete’s foot, jock itch, ringworm, and yeast infections (cutaneous candidiasis, vaginal candidiasis, and superficial dermatologic Infections). It belongs to the topical antifungal family of medicines. It can be used on its own or in combination with other drugs. According to NCBI, athlete’s foot is a frequent ailment among athletes. Between 3% to 15% of the population is estimated to have ailment issues. It is more common among men and the elderly. According to the Centre for Disease Control and Prevention (CDC), vaginal candidiasis is common in the US, it is the second most common type of vaginal infection after bacterial vaginal infections as of 2020. An estimated 1.4 million outpatient visits for vaginal candidiasis occur annually in the US.
(Get 15% Discount on Buying this Report)
A full report is available at : https://orionmarketreports.com/global-clotrimazole-vaginal-cream/92800/
The hospital sub-segment is anticipated to propel the overall growth of the market owing to the increasing cases of infectious skin diseases such as jock itch, ringworm, and yeast infections among others. The rise in the adoption of clotrimazole products in hospitals for the treatment of these infectious skin diseases is the major cause of the growth of the segment. Clotrimazole is a topical antifungal that is used to treat yeast infections on the skin. It works by eradicating the infection-causing yeast. The treatment of such infectious diseases is done in hospitals and therefore, the segment is propelling the growth of the market.
Market Coverage
The market number available for – 2022-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
By Distribution Channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape- Bayer AG, Glenmark Pharmaceuticals Ltd., G&W laboratories Inc., Lannett Inc., Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc.,and Teva Pharmaceutical Industries Ltd. among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How are playersaddressing challenges to sustain growth?
- Where is the investment opportunity?
Global Clotrimazole Vaginal Cream Market Report by Segment
By Type
- 15g
- 30g
- 45g
By Application
- FootAilment
- Jock Itch
- Ringworm
- Yeast infections
By Distribution Channel
- Hospitals
- Drug Stores
- Others
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name : Orion Market Reports
Contact Person : Mr. Anurag Tiwari
Email : Info@orionmarketreports.com
Contact No : +91 780-304-0404
This release has been published on Global market Post
Global market Post is not responsible for any content included in this release.
